Bank of America has downgraded Molina Healthcare (NYSE:
MOH) from Buy to Underperform and has lowered the price objective from $30 to $18.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.